367 related articles for article (PubMed ID: 30575175)
1. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis.
Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis.
Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation.
Liang JJ; Elafros MA; Mullen MT; Muser D; Hayashi T; Enriquez A; Pathak RK; Zado ES; Santangeli P; Arkles JS; Schaller RD; Supple GE; Frankel DS; Garcia FC; Deo R; Lin D; Riley MP; Nazarian S; Dixit S; Marchlinski FE; Callans DJ
J Cardiovasc Electrophysiol; 2018 Jun; 29(6):823-832. PubMed ID: 29513397
[TBL] [Abstract][Full Text] [Related]
4. "As Needed" nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study.
Zado ES; Pammer M; Parham T; Lin D; Frankel DS; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2019 May; 30(5):631-638. PubMed ID: 30706975
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Freeman JV; Shrader P; Pieper KS; Allen LA; Chan PS; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel JA; Singer DE; Go AS; Hylek EM; Steinberg BA; Peterson ED; Piccini JP
Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007612. PubMed ID: 31830822
[TBL] [Abstract][Full Text] [Related]
6. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry.
Okumura Y; Nagashima K; Arai M; Watanabe R; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Shimizu W; Iwasaki YK; Hayashi H; Harada T; Nakajima I; Okumura K; Koyama J; Tokuda M; Yamane T; Momiyama Y; Tanimoto K; Soejima K; Nonoguchi N; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Satomi K; Yazaki Y; Watari Y;
Circ J; 2019 Nov; 83(12):2418-2427. PubMed ID: 31619591
[TBL] [Abstract][Full Text] [Related]
7. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
Winkle RA; Mead RH; Engel G; Kong MH; Patrawala RA
Europace; 2014 Feb; 16(2):195-201. PubMed ID: 24036378
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
Noseworthy PA; Yao X; Deshmukh AJ; Van Houten H; Sangaralingham LR; Siontis KC; Piccini JP; Asirvatham SJ; Friedman PA; Packer DL; Gersh BJ; Shah ND
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26541393
[TBL] [Abstract][Full Text] [Related]
9. Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis.
Toso E; Peyracchia M; Matta M; D'Ascenzo F; Gaita F; Kornej J; Hindricks G; Jared Bunch T; Saliba W
Int J Cardiol; 2018 Nov; 270():172-179. PubMed ID: 29945808
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of stroke and bleeding post-atrial fibrillation ablation.
Joza J; Samuel M; Jackevicius CA; Behlouli H; Jia J; Koh M; Tsadok MA; Tang ASL; Verma A; Pilote L; Essebag V
J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1355-1362. PubMed ID: 30047574
[TBL] [Abstract][Full Text] [Related]
11. Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.
Kochhäuser S; Alipour P; Haig-Carter T; Trought K; Hache P; Khaykin Y; Wulffhart Z; Pantano A; Tsang B; Birnie D; Verma A
J Cardiovasc Electrophysiol; 2017 Mar; 28(3):273-279. PubMed ID: 27933666
[TBL] [Abstract][Full Text] [Related]
12. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment.
Riley MP; Zado E; Hutchinson MD; Lin D; Bala R; Garcia FC; Callans DJ; Cooper JM; Verdino RJ; Dixit S; Marchlinski FE
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):591-6. PubMed ID: 24533561
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
Kanaoka K; Nishida T; Iwanaga Y; Nakai M; Tonegawa-Kuji R; Nishioka Y; Myojin T; Okada K; Noda T; Kusano K; Miyamoto Y; Saito Y; Imamura T
Eur Heart J; 2024 Feb; 45(7):522-534. PubMed ID: 38117227
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience of uninterrupted oral anticoagulants during atrial fibrillation ablation in elderly patients: a comparison with non-elderly patients.
Matsunaga-Lee Y; Egami Y; Yanagawa K; Nakamura H; Matsuhiro Y; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Yano M; Yamato M; Shutta R; Sakata Y; Nishino M; Tanouchi J
Heart Vessels; 2020 Oct; 35(10):1454-1462. PubMed ID: 32335715
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.
Gunawardene MA; Dickow J; Schaeffer BN; Akbulak RÖ; Lemoine MD; Nührich JM; Jularic M; Sinning C; Eickholt C; Meyer C; Moser JM; Hoffmann BA; Willems S
J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023
[TBL] [Abstract][Full Text] [Related]
16. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
[TBL] [Abstract][Full Text] [Related]
18. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
[TBL] [Abstract][Full Text] [Related]
19. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
20. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
